Raymond James Financial, Inc. Common Stock (RJF)

158.32
+2.74 (1.76%)
NYSE · Last Trade: Apr 30th, 9:08 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close155.58
Open153.98
Bid150.47
Ask158.42
Day's Range153.85 - 158.76
52 Week Range133.89 - 177.66
Volume1,299,799
Market Cap31.19B
PE Ratio (TTM)20.14
EPS (TTM)7.9
Dividend & Yield2.160 (1.36%)
1 Month Average Volume1,475,909

Chart

About Raymond James Financial, Inc. Common Stock (RJF)

Raymond James Financial is a diversified financial services company that provides a range of investment and wealth management solutions. The firm offers services such as financial planning, asset management, investment banking, and capital markets support, catering to both individual and institutional clients. Through its network of financial advisors and professionals, Raymond James aims to deliver personalized strategies and guidance, helping clients navigate their financial goals and market complexities. The company is also involved in various sectors including equity and fixed income, further solidifying its presence in the financial landscape. Read More

News & Press Releases

Why Universal Health Services (UHS) Stock Is Up Today
What Happened? Shares of hospital management company Universal Health Services (NYSE:UHS) jumped 3.8% in the afternoon session after the company reported fir...
Via StockStory · April 29, 2026
Lisa Detanna Named #14 in CA to Barron’s List of Top 1,500 Financial Advisors
Lisa Detanna, Private Wealth Advisor, Managing Director of Global Wealth Solutions Group at Raymond James & Associates, member New York Stock Exchange/SIPC, located at 9595 Wilshire Blvd #801, Beverly Hills, CA 90212, was among the Raymond James-affiliated advisors named to the Barron’s list of Top 1,500 Financial Advisors. The list, which recognizes advisors from national, regional and independent firms, was released online March 20, 2026.
By Raymond James · Via Business Wire · April 29, 2026
Trustmark (TRMK) Q1 2026 Earnings Transcriptfool.com
Trustmark (TRMK) Q1 2026 Earnings Transcript
Via The Motley Fool · April 29, 2026
Raymond James Financial Inc (NYSE:RJF) Reports Q2 2026 Earnings Beat, Revenue Misschartmill.com
Via Chartmill · April 22, 2026
5 Must-Read Analyst Questions From Raymond James’s Q1 Earnings Call
Raymond James delivered a fiscal second quarter that surpassed Wall Street’s revenue and adjusted profit expectations, with management attributing performanc...
Via StockStory · April 29, 2026
Why World Kinect (WKC) Stock Is Up Today
What Happened? Shares of energy management company World Kinect (NYSE:WKC) jumped 1.8% in the afternoon session after Raymond James raised its price target o...
Via StockStory · April 28, 2026
1 Value Stock to Research Further and 2 That Underwhelm
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...
Via StockStory · April 28, 2026
Why First BanCorp (FBP) Stock Is Trading Up Today
What Happened? Shares of puerto Rican financial institution First BanCorp (NYSE:FBP) jumped 3.1% in the morning session after Raymond James upgraded the stoc...
Via StockStory · April 27, 2026
Post Malone 2026 Concert Tickets: Grab Discounted Seats Now with CITY10 at CapitalCityTickets.com
Post Malone is taking over stadiums in 2026 with The BIG ASS Stadium Tour Part 2, featuring massive productions, genre-blending hits, and high-energy performances alongside Jelly Roll and special guest Carter Faith. Expect chart-toppers like “I Had Some Help,” “Circles,” “Rockstar,” and new music in unforgettable live settings. Don’t pay full price — score discounted Post Malone tickets online right now.
Via AB Newswire · April 27, 2026
This Insulet Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Fridaybenzinga.com
Morgan Stanley downgraded FCX and Raymond James downgraded IRDM, while MoffettNathanson downgraded DKNG and Rothschild & Co downgraded PODD. See analyst ratings.
Via Benzinga · April 24, 2026
Expert Matchmaker in Tampa Report by CX Research Institute
Tampa, FL - CX Research Institute announced today the publication of its comprehensive research report evaluating the best expert matchmakers in the Tampa Bay metropolitan area. VIDA Select earned the top ranking with a score of 92 out of 100 points, leading seven other prominent matchmaking and dating services in a rigorous comparative analysis.
Via AB Newswire · April 24, 2026
2 Large-Cap Stocks with Solid Fundamentals and 1 We Turn Down
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it m...
Via StockStory · April 24, 2026
RJF Q1 Deep Dive: Adviser Recruiting and Technology Investment Drive Growth Amid Stable Margins
Financial services firm Raymond James Financial (NYSE:RJF) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 25.2% year o...
Via StockStory · April 23, 2026
Raymond James (RJF) Q2 2026 Earnings Transcriptfool.com
Raymond James (RJF) Q2 2026 Earnings Transcript
Via The Motley Fool · April 22, 2026
Raymond James (NYSE:RJF) Reports Strong Q1 CY2026
Financial services firm Raymond James Financial (NYSE:RJF) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 25.2% year on yea...
Via StockStory · April 22, 2026
Raymond James Financial Reports Fiscal Second Quarter of 2026 Results
ST. PETERSBURG, Fla., April 22, 2026 (GLOBE NEWSWIRE) --
By Raymond James Financial · Via GlobeNewswire · April 22, 2026
Raymond James Is Betting Okta Stock Can Gain from Here. Should You Buy Shares Now?
Okta has gone from “SaaS‑pocalypse” casualty to profitable cash generator, and with identity security sitting at the center of how enterprises manage both humans and AI agents, an upside gap to Street targets makes the risk‑reward look attractive.
Via Barchart.com · April 21, 2026
Jazz Pharmaceuticals Stock, a Barchart Favorite, Trends Higher as Trump Renews Cannabis Hopes. Should You Buy JAZZ Here?
Jazz Pharmaceuticals stock pops as President Trump signals renewed urgency to reclassify cannabis as Schedule III drug. Technicals signal further upside ahead in JAZZ shares.
Via Barchart.com · April 21, 2026
EOG Resources Quarterly Earnings Preview: What You Need to Know
EOG Resources is gearing up to announce its Q1 results by early May, and analysts expect its EPS to rise in the low single digits.
Via Barchart.com · April 21, 2026
What You Need to Know Ahead of Motorola Solutions’ Earnings Release
Motorola Solutions is expected to release its fiscal first-quarter earnings soon, and analysts predict its earnings will fall marginally.
Via Barchart.com · April 21, 2026
Raymond James (RJF) Q1 Earnings: What To Expect
Financial services firm Raymond James Financial (NYSE:RJF) will be announcing earnings results this Wednesday after market close. Here’s what investors shoul...
Via StockStory · April 20, 2026
Why Okta (OKTA) Stock Is Up Today
What Happened? Shares of identity management company Okta (NASDAQ:OKTA) jumped 4.9% in the afternoon session after analyst upgrades from Raymond James and Ba...
Via StockStory · April 20, 2026
3 Market-Beating Stocks on Our Watchlist
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta y...
Via StockStory · April 16, 2026
Dear UnitedHealth Stock Fans, Mark Your Calendars for April 21
UNH stock is facing very tough challenges as the company gears up to report first-quarter earnings.
Via Barchart.com · April 9, 2026
Levi Strauss Just Entered Overbought Territory. Is It Too Late to Buy LEVI Stock Here?
Levi’s shares push higher on a strong Q1 release and raised guidance for the full year. Here’s why LEVI stock is worth buying into post-earnings strength.
Via Barchart.com · April 8, 2026